Stay updated on Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The date has been updated from February 6, 2025, to March 5, 2025.
    Difference
    0.7%
    Check dated 2025-03-10T20:19:25.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T09:56:53.000Z thumbnail image
  5. Check
    33 days ago
    No Change Detected
  6. Check
    40 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting NLM-NCBI services and products, along with an updated date of February 6, 2025, while the previous date of January 23, 2025, has been removed.
    Difference
    6%
    Check dated 2025-02-10T01:51:11.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T00:49:56.000Z thumbnail image
  8. Check
    54 days ago
    Change Detected
    Summary
    New content was added on January 23, 2025, following the deletion of previous content on January 16, 2025.
    Difference
    0.3%
    Check dated 2025-01-26T23:57:14.000Z thumbnail image
  9. Check
    61 days ago
    Change Detected
    Summary
    The website has been updated to version 2.14.1 on January 16, 2025, following the removal of version 2.14.0 on December 27, 2024.
    Difference
    1%
    Check dated 2025-01-19T12:13:01.000Z thumbnail image

Stay in the know with updates to Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.